NEU neuren pharmaceuticals limited

Ann: Q2 2024 update, page-33

  1. 4,019 Posts.
    lightbulb Created with Sketch. 988
    Oh god, just more half-arsed, factually incorrect gumph masqueradeing as journalism. This time from Joseph Carbone from The Australian.

    Acadia did not report ‘weaker net sales’ of Daybue. They are stronger than the previous quarter.

    2Q US$84.6m compared to 1Q US75.9m.

    Even if Daybue sales subsequently only hit the lower end of the revised full year guidance of US$340m - US$370m, the next two Qs will be at least US$90m each. Another increase in net sales.

    Hit this minimum target and a very juicy milestone payment is in the bag. Too much negativity going on here.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.